Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥5,401,000 | -¥1,510,000 | ¥2,420,000 | -¥1,891,000 |
| Dep. & Amort. | ¥1,336,000 | ¥1,360,000 | ¥1,104,000 | ¥1,345,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥340,000 | ¥2,500,000 | -¥3,487,000 | -¥2,760,000 |
| Other Non-Cash | ¥4,857,000 | -¥438,000 | ¥924,000 | ¥2,090,000 |
| Operating Cash Flow | ¥1,132,000 | ¥1,912,000 | ¥961,000 | -¥1,216,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥11,779,000 | -¥377,000 | -¥266,000 | -¥8,488,000 |
| Net Acquisitions | ¥108,000 | -¥6,494,000 | -¥545,000 | ¥0 |
| Inv. Purchases | -¥528,000 | -¥977,000 | -¥42,000 | -¥420,000 |
| Inv. Sales/Matur. | ¥859,000 | ¥948,000 | ¥25,000 | -¥375,000 |
| Other Inv. Act. | -¥1,000 | ¥20,000 | -¥406,000 | ¥1,000 |
| Investing Cash Flow | -¥11,341,000 | -¥6,880,000 | -¥1,234,000 | -¥9,282,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥9,951,000 | -¥50,000 | ¥0 | ¥0 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥68,000 | -¥1,980,000 | -¥1,000 | -¥1,000 |
| Other Fin. Act. | -¥121,000 | ¥0 | -¥48,000 | -¥55,000 |
| Financing Cash Flow | ¥9,762,000 | -¥2,030,000 | -¥49,000 | -¥56,000 |
| Forex Effect | -¥2,565,000 | ¥1,968,000 | -¥1,347,000 | ¥1,035,000 |
| Net Chg. in Cash | -¥3,012,000 | -¥5,030,000 | -¥1,669,000 | -¥9,519,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥22,006,000 | ¥27,036,000 | ¥28,705,000 | ¥38,224,000 |
| End Cash | ¥18,994,000 | ¥22,006,000 | ¥27,036,000 | ¥28,705,000 |
| Free Cash Flow | -¥10,647,000 | ¥1,535,000 | ¥695,000 | -¥9,704,000 |